Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis.
<h4>Rationale</h4>Tuberculosis remains a worldwide problem, particularly with the advent of multi-drug resistance. Shortening therapy duration for Mycobacterium tuberculosis is a major goal, requiring generation of optimal kill rate and resistance-suppression. Combination therapy is requ...
Saved in:
Main Authors: | George L Drusano, Michael Neely, Michael Van Guilder, Alan Schumitzky, David Brown, Steven Fikes, Charles Peloquin, Arnold Louie |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/1256c6075bff4f35aa29eb4d2784a757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
by: Ashley N. Brown, et al.
Published: (2015) -
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
by: Nicholas D. Walter, et al.
Published: (2021) -
The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of <italic toggle="yes">Mycobacterium tuberculosis</italic> as Determined in a Hollow-Fiber Infection Model
by: G. L. Drusano, et al.
Published: (2010) -
The effect of stretch–shortening magnitude and muscle–tendon unit length on performance enhancement in a stretch–shortening cycle
by: Martin Groeber, et al.
Published: (2021) -
A shortened history of England
by: Macaulay Trevelyan, George
Published: (1942)